Bio Rad Laboratories Stock Buy Hold or Sell Recommendation
| BIO Stock | USD 290.86 1.89 0.65% |
Considering the 90-day investment horizon and your complete indifference towards market risk, our recommendation regarding Bio Rad Laboratories is 'Strong Hold'. Macroaxis provides Bio Rad buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bio Rad positions. The advice algorithm takes into account all of Bio Rad's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Bio Rad's buy or sell advice are summarized below:
Real Value 370.87 | Target Price 523.6 | Hype Value 291.28 | Market Value 290.86 | Naive Value 274.55 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bio Rad Laboratories given historical horizon and risk tolerance towards Bio Rad. When Macroaxis issues a 'buy' or 'sell' recommendation for Bio Rad Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Bio |
Execute Bio Rad Buy or Sell Advice
The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Rad Laboratories. Macroaxis does not own or have any residual interests in Bio Rad Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio Rad's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bio Rad Trading Alerts and Improvement Suggestions
| Bio Rad Laboratories generated a negative expected return over the last 90 days | |
| The company reported the last year's revenue of 2.67 B. Reported Net Loss for the year was (637.32 M) with profit before taxes, overhead, and interest of 1.57 B. | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Core Clinical Molecular Diagnostics Market to Reach 11.9 Billion, Globally, by 2032 at 9.5 percent CAGR Allied Market Research |
Bio Rad Returns Distribution Density
The distribution of Bio Rad's historical returns is an attempt to chart the uncertainty of Bio Rad's future price movements. The chart of the probability distribution of Bio Rad daily returns describes the distribution of returns around its average expected value. We use Bio Rad Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio Rad returns is essential to provide solid investment advice for Bio Rad.
| Mean Return | -0.12 | Value At Risk | -3.47 | Potential Upside | 3.74 | Standard Deviation | 2.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio Rad historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bio Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Bio Rad is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Rad Laboratories backward and forwards among themselves. Bio Rad's institutional investor refers to the entity that pools money to purchase Bio Rad's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Thompson, Siegel & Walmsley Llc | 2023-12-31 | 348.5 K | Massachusetts Financial Services Company | 2023-12-31 | 322.3 K | Goldman Sachs Group Inc | 2023-12-31 | 288.7 K | Hound Partners, Llc | 2023-12-31 | 261.7 K | Northern Trust Corp | 2023-12-31 | 252.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 250.1 K | Westfield Capital Management Company, Lp | 2023-12-31 | 247.2 K | Parnassus Investments, Llc | 2023-12-31 | 237.8 K | Norges Bank | 2023-12-31 | 226.5 K | Vanguard Group Inc | 2023-12-31 | 2.4 M | Blackrock Inc | 2023-12-31 | 1.5 M |
Bio Rad Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 24.2M | (52.1M) | 46.1M | (158.8M) | (46.3M) | (44.0M) | |
| Change In Cash | 228.5M | 4.5M | (196.0M) | (36.6M) | (30.3M) | (28.7M) | |
| Free Cash Flow | 359.4M | 476.4M | 535.7M | 80.3M | 218.3M | 229.2M | |
| Depreciation | 134.2M | 138.1M | 133.8M | 137.3M | 192.4M | 202.0M | |
| Other Non Cash Items | (1.5B) | (3.4B) | (3.7B) | 5.3B | 1.2B | 1.3B | |
| Capital Expenditures | 98.5M | 98.9M | 120.8M | 114.2M | 156.7M | 84.5M | |
| Net Income | 1.8B | 3.8B | 4.2B | (3.6B) | (637.3M) | (605.5M) | |
| End Period Cash Flow | 662.7M | 667.1M | 471.1M | 434.5M | 404.0M | 286.4M | |
| Change To Netincome | (2.0B) | (3.5B) | (3.8B) | 5.3B | 4.7B | 5.0B | |
| Change Receivables | 31.7M | 21.5M | 35.3M | 68.2M | 78.4M | 82.3M | |
| Net Borrowings | (1.1M) | (426.9M) | (3.0M) | 1.2B | 1.4B | 1.4B | |
| Investments | (119.3M) | 119.6M | (538.2M) | (994.2M) | (110.5M) | (116.1M) |
Bio Rad Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Rad or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Rad's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.21 | |
β | Beta against NYSE Composite | 1.84 | |
σ | Overall volatility | 2.00 | |
Ir | Information ratio | -0.09 |
Bio Rad Volatility Alert
Bio Rad Laboratories exhibits very low volatility with skewness of -0.02 and kurtosis of 0.6. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Rad's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Rad's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bio Rad Fundamentals Vs Peers
Comparing Bio Rad's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Rad's direct or indirect competition across all of the common fundamentals between Bio Rad and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Rad or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Rad's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bio Rad to competition |
| Fundamentals | Bio Rad | Peer Average |
| Return On Equity | -0.0694 | -0.31 |
| Return On Asset | 0.0177 | -0.14 |
| Profit Margin | (0.24) % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 8.37 B | 16.62 B |
| Shares Outstanding | 23.42 M | 571.82 M |
| Shares Owned By Insiders | 15.23 % | 10.09 % |
| Shares Owned By Institutions | 81.70 % | 39.21 % |
| Number Of Shares Shorted | 564.75 K | 4.71 M |
| Price To Earning | 2.90 X | 28.72 X |
| Price To Book | 0.98 X | 9.51 X |
| Price To Sales | 3.28 X | 11.42 X |
| Revenue | 2.67 B | 9.43 B |
| Gross Profit | 1.57 B | 27.38 B |
| EBITDA | 576.2 M | 3.9 B |
| Net Income | (637.32 M) | 570.98 M |
| Cash And Equivalents | 434.21 M | 2.7 B |
| Cash Per Share | 62.03 X | 5.01 X |
| Total Debt | 1.41 B | 5.32 B |
| Debt To Equity | 0.16 % | 48.70 % |
| Current Ratio | 5.50 X | 2.16 X |
| Book Value Per Share | 306.51 X | 1.93 K |
| Cash Flow From Operations | 374.94 M | 971.22 M |
| Short Ratio | 3.22 X | 4.00 X |
| Earnings Per Share | (21.81) X | 3.12 X |
| Price To Earnings To Growth | 1.19 X | 4.89 X |
| Target Price | 409.8 | |
| Number Of Employees | 8.03 K | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 8.76 B | 19.03 B |
| Total Asset | 12.3 B | 29.47 B |
| Retained Earnings | 9.26 B | 9.33 B |
| Working Capital | 2.53 B | 1.48 B |
Note: Acquisition by Michael Crowley of 520 shares of Bio Rad subject to Rule 16b-3 [view details]
Bio Rad Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0295 | |||
| Daily Balance Of Power | (0.21) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 294.81 | |||
| Day Typical Price | 293.49 | |||
| Market Facilitation Index | 8.82 | |||
| Price Action Indicator | (4.89) | |||
| Period Momentum Indicator | (1.89) |
About Bio Rad Buy or Sell Advice
When is the right time to buy or sell Bio Rad Laboratories? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 11.0M | 1.2B | 1.4B | 1.5B | Total Assets | 17.8B | 13.5B | 12.3B | 12.9B |
Use Investing Ideas to Build Portfolios
In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio Rad Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.56) | Earnings Share (21.81) | Revenue Per Share 91.453 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0177 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.